Histone Therapeutics is a biotechnology company at the forefront of precision epigenetic reprogramming that is focused on enhancing cell function and treating disease by controlling gene regulation. Our team shares the conviction that new drug modalities based on protein modifiers of chromatin remodeling could provide new options for treating disease and enhancing the human condition.